Sign up for updates!
Get news from UC Davis MIND Institute in your inbox.
Stem Cells
UC Davis designated a NORD Rare Disease Center of Excellence
Recognition is a testament to the university’s leadership in researching and treating rare diseases
Top Stories
-
General Health NewsOctubure 20, 2025Declaración del Instituto MIND de UC Davis sobre el acetaminofeno y el autismo
El Instituto MIND de UC Davis da a conocer las últimas investigaciones sobre el acetaminofeno y el autismo.
Leer más -
MIND InstituteSEPTEMBER 18, 2025UC Davis scientists pioneer stem cell gene therapy for Angelman syndrome
UC Davis Health researchers are testing a groundbreaking new therapy for the rare neurodevelopmental condition Angelman syndrome.
Read More -
MIND InstituteSEPTEMBER 17, 2025Autistic children more likely to experience persistent gastrointestinal problems
Stomach issues in autistic children are linked to greater challenges with sleep, communication, sensory processing and behavior, finds a study by the UC Davis MIND Institute.
Read More -
MIND InstituteSEPTEMBER 08, 2025Program helps over 800 families navigate resources and services for autism and other conditions
The UC Davis MIND Institute’s Family Navigator Program offers help accessing services, therapies and resources after a diagnosis of autism or another neurodevelopmental condition.
Read More -
ResearchSEPTEMBER 03, 2025Dream team to develop in utero gene editing therapy for a rare neurological genetic disorder
Professor Aijun Wang won a $3.2 million NIH grant to develop a cure to Dup15q syndrome using an in-utero gene editing formula.
Read More